|
Unlock ST Premium FREE Trial: Discover top stock picks & smart tools
|
|
|
Good morning!
US stock futures advanced on Monday, with Dow Jones futures rising 0.76%, S&P 500 futures gaining 0.47%, and Nasdaq-100 futures climbing 0.30%, signalling a potential recovery after all three indexes recorded losses last week.
Investor attention remained focused on the AI sector ahead of major corporate earnings and inflation data. However, Nvidia shares fell 4% in premarket trading amid reports of an investigation involving CEO Jensen Huang.
Meanwhile, Asian markets gained ground, with South Koreaโs Kospi and Japanโs Nikkei rising over 1%. Wholesale trade data is the week's key initial economic release.
|
|
|
Find undervalued stocks with positive ratings
|
|
|
|
ADVERTISEMENT
|
Sponsored content
|
Attention! Before You Buy Another AI Stock...
If you're buying Nvidia or any other AI stock right now, read this first.
Most investors are crowded into the wrong side of the AI trade.
The stocks are the obvious play. But the infrastructure underneath is where the real potential is.
Mastercard was the pick-and-shovels play of the e-commerce boom. Its stock has returned over 12,000% since its 2006 IPO.
But the question is... what is the pick-and-shovels play of AI?
Find Out in This Briefing on the AI Gold Rush โ
|
|
|
๐ PRE-MARKET MOVERS TOP GAINERS BEFORE THE BELL
Generation Essentials Group (TGE)
+27.46%
stock soared to $0.45 in pre-market trading following the announcement of four premium hotel asset injections.
INLIF Ltd (NASDAQ: INLF)
+28.53%
shares are trading up at $0.29 at the time of writing following the filing of a 6-K/A form with the SEC.
Vir Biotechnology Inc (VIR)
+16.71%
grew over to $14.25 in pre-market trading today after announcing new, expanded data from the Phase 2 SOLSTICE trial evaluating monthly subcutaneous administration of elebsiran and tobevibart in adults with chronic hepatitis delta (CHD).
Cabaletta Bio Inc (CABA)
+6.92%
jumped about to $1.39 in pre-market trading Monday after announcing new Phase 1/2 clinical data on resecabtagene autoleucel (rese-cel) to be presented in one oral and two poster presentations at the American College of Rheumatology (ACR) Convergence 2026 annual meeting in Orlando, FL.
|
|
|
|
ADVERTISEMENT
|
Sponsored content
|
America's Economist Explains This Stock Market in Three Words
Something strange is happening in the stock market. Dr. Mark Skousen, the economist who called the '95 tech boom and the 2009 bottom, has boiled it down to three words. And if he's right, what happens next could make or break your retirement.
Watch the one move he says to make now โ free, right here.
|
|
|
๐ฃ ANALYST UPGRADES & DOWNGRADES FRESH WALL STREET CALLS
Seaport Research Partners turned bullish on SiTime Corp (SITM)
BUY,
upgrading the stock and assigning a $425 price target, representing potential upside of 1.94% from Friday's close.
Centrus Energy Corp (LEU)
has won the favor of Roth Capital's equity research team. The firm upgraded the shares from Neutral to
BUY
and moved its price target to $115, suggesting 9.94% additional upside for the stock.
JinkoSolar Holding Co., Ltd (JKS)
received an upgrade from analysts at UBS, who also set their one-year price target on the stock to $17. They changed their rating on JKS to
BUY
from Neutral in a recently issued research note.
BMO Capital Markets reduced its rating on Globus Medical Inc (GMED)
stock to MARKET PERFORM
from Outperform and assigned the price target to $78.
Evercore ISI analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Five9 Inc (FIVN)
has been changed to IN-LINE
from Outperform and the new price target is set at $24.
Analysts at Raymond James downgraded ARS Pharmaceuticals Inc (SPRY)
stock to OUTPERFORM
from Strong Buy, and the new price target is set at $17.
|
|
|
|
ADVERTISEMENT
|
Sponsored content
|
|
|
|
๐ LATEST INSIDER ACTIVITY EXECUTIVE BUYS & SELLS
OBOOK Holdings Inc (OWLS)
BUY
โ General Counsel, Lu Ying, declared the purchase of shares taking place on Nov 05 '26 at $2.3 for some 3 shares. The transaction amount was around $7.
Jewett-Cameron Trading Company Ltd (JCTC)
BUY
โ 10% Owner, AJB Investment Fund II, LP bought on Nov 06 '26 a total of 735 shares at $2.85 on average. The purchase cost the insider an estimated $2,095.
Sharkninja Inc (SN)
SELL
โ Chief Executive Officer, Barrocas Mark, announced the sale of shares taking place on Nov 06 '26 at $220.93 for some 113156 shares. The total came to more than $25 million.
Ryerson Holding Corp (RYZ)
SELL
โ EVP, Greiff Andrew S sold on Nov 04 '26 a total 3000 shares at $32.1 on average. The insiderโs sale generated proceeds of almost $96,300.
|
|
|
|
ADVERTISEMENT
|
Sponsored content
|
5 Stocks to Buy for Q4 2026
This year has thrown the market a war with Iran, $100 oil and the Fed's first rate hike since 2023. Stocks climbed anyway. This free report reveals 5 companies with the earnings and catalysts to finish 2026 strong. See which ones made our list.
Click here for your free report
|
|
|
๐ EARNINGS TO WATCH TODAY
Top US earnings releases scheduled for today include Plug Power Inc (PLUG). It will announce its September 2026 financial results. The company is expected to report earnings of -$0.06 per share from revenues of $193.33M in the three-month period.
Analysts expect MARA Holdings Inc (MARA) to report a net income (adjusted) of -$0.1 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended September 2026 is predicted to come in at $176.13M.
AST SpaceMobile Inc (ASTS), due to announce earnings after the market closes today, is expected to report earnings of -$0.45 per share on revenues of $46M for the recently concluded three-month period.
|
|
|
That's it for today. Thanks for reading. Good luck out there!
Best Regards,
Stocks Telegraph Team
|
|
|
Unlock Full Market Intelligence
Get unlimited screener access, real-time analyst ratings, insider alerts, and exclusive stock breakdowns โ all in one premium subscription.
Best value on the yearly plan ยท Cancel anytime
|
|
|
Disclaimer:
Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.
|
|
|